Published : 6 May, 2024
Dr. Sudhir Kumar Rawal, an oncologist at RGCIRC , discussed the significant health impact of prostate cancer in India, highlighting its rising incidence and challenges in early detection. He emphasized advancements in treatments like HIFU therapy, which offers a minimally invasive option for localized prostate cancer. Dr. Rawal noted RGCIRC’s comprehensive approach to diagnosis and staging using advanced techniques like MRI fusion biopsies. He also highlighted ongoing research in genetic testing and targeted therapies, underscoring the center’s commitment to improving patient outcomes through personalized treatment plans.
